Savanna Biotherapeutics, Inc.

Form D Filings

Location
Aliso Viejo, CA
Industry Group
Biotechnology
Entity Type
Corporation
CIK
0001873404
Previous Names
Savanna Biotherapeutics, Inc., NovoGlia, Inc.
All SEC Filings
View on sec.gov
Date Filed Security Types Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
6/30/2025 Equity $12,999,997 $59,999,993 $46,999,996 6/12/2025 6/28/2025 D 000187340425000002
11/18/2022 Equity $24,304,480 $54,304,476 $29,999,996 11/3/2022 11/17/2022 D 000187340422000002